APA (7th ed.) Citation

Zhang, J., He, L., Chen, X., Tu, Y., Kostov, B., Cabedo, J., . . . García Gil, E. (2025). Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up. Dermatology & Therapy, 15(11), 3285. https://doi.org/10.1007/s13555-025-01526-8

Chicago Style (17th ed.) Citation

Zhang, Jianzhong, Li He, Xue Chen, Ying Tu, Belchin Kostov, Judit Cabedo, Tolga Baykal, and Esther García Gil. "Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up." Dermatology & Therapy 15, no. 11 (2025): 3285. https://doi.org/10.1007/s13555-025-01526-8.

MLA (9th ed.) Citation

Zhang, Jianzhong, et al. "Efficacy and Safety of Sarecycline in Chinese Patients with Moderate-to-Severe Acne Vulgaris: Randomized Phase 3 Clinical Trial with Open-Label Follow-Up." Dermatology & Therapy, vol. 15, no. 11, 2025, p. 3285, https://doi.org/10.1007/s13555-025-01526-8.